首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1547357

全球醫用大麻市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Medical Marijuana Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球醫用大麻市場需求預計將從 2023 年的 189.7 億美元達到近 234 億美元的市場規模，2024-2032 年研究期間複合年成長率為 2.36%。

醫用大麻是指利用大麻植物或其衍生物來治療疾病症狀和其他病症。它通常用於緩解慢性疼痛、減少化療引起的噁心和嘔吐、刺激愛滋病患者的食慾，以及治療多發性硬化症的痙攣。它含有 THC 和 CBD 等大麻素，與人體的內源性大麻素系統相互作用以提供治療作用。不同地區醫用大麻使用的合法化和監管差異很大，反映了不同的社會態度和政府對其使用的政策。

市場動態

人們對大麻治療功效的日益認可是醫用大麻市場的主要動力。研究和臨床研究已證明其在治療癲癇、慢性疼痛和多發性硬化症等多種疾病方面的功效，從而在市場上得到更廣泛的接受和採用。各地區醫用大麻的逐步合法化和法規核准正在顯著提振市場。隨著越來越多的國家和州將其用於醫療目的合法化，市場持續成長。此外，患者和醫療保健提供者對大麻潛在健康益處的認知不斷提高，正在推動市場成長。關於大麻治療用途的教育和資訊傳播的增加正在鼓勵更多患者尋求大麻治療。此外，種植和萃取技術的進步正在提高大麻產品的品質和一致性，增強其吸引力和可靠性。這些創新使得標準化和高效大麻產品的生產成為可能，並滿足醫學界的嚴格要求。此外，製藥公司對醫用大麻領域的投資和參與不斷增加，透過支持研究、產品開發和分銷管道，有助於市場成長。然而，監管障礙和法律複雜性可能會阻礙未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球醫用大麻市場的每個細分市場進行了包容性評估。醫用大麻產業的成長和趨勢為本研究提供了整體方法。

市場區隔

醫用大麻市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

花
油和酊劑

按申請

癌症
慢性疼痛
憂鬱和焦慮
關節炎
糖尿病
青光眼
偏頭痛
癲癇
多發性硬化症
愛滋病
肌萎縮側索硬化症
阿茲海默症
創傷後壓力症候群（PTSD）
帕金森氏症
抽動穢語症
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲醫用大麻市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。醫用大麻市場的主要參與者包括 Tilray、Aurora Cannabis、頂篷 Growth Corporation、Aphria Inc.、Maricann Group Inc.、Tikun Olam Ltd.、MedReleaf。 Corp.、GW Pharmaceuticals Plc.、Cannabis Sativa Inc.、Medical Marijuana Inc.。新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：醫用大麻公司的競爭格局

醫用大麻市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Tilray

公司概況
公司收入
產品
最新動態

Aurora Cannabis

公司概況
公司收入
產品
最新動態

Canopy Growth Corporation

公司概況
公司收入
產品
最新動態

Aphria Inc.

公司概況
公司收入
產品
最新動態

Maricann Group Inc.

公司概況
公司收入
產品
最新動態

Tikun Olam Ltd.

公司概況
公司收入
產品
最新動態

MedReleaf. Corp.

公司概況
公司收入
產品
最新動態

GW Pharmaceuticals Plc.

公司概況
公司收入
產品
最新動態

Cannabis Sativa Inc.

公司概況
公司收入
產品
最新動態

Medical Marijuana Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215864

The global demand for Medical Marijuana Market is presumed to reach the market size of nearly USD 23.4 Billion by 2032 from USD 18.97 Billion in 2023 with a CAGR of 2.36% under the study period 2024-2032.

Medical marijuana denotes the utilization of the cannabis plant or its derivatives to treat symptoms of illness and other conditions. It is often prescribed to alleviate chronic pain, lower nausea, and vomiting concerned with chemotherapy, stimulate appetite in patients with AIDS, and treat spasticity in multiple sclerosis. It contains cannabinoids such as THC and CBD, which interact with the body's endocannabinoid system to provide therapeutic effects. The legalization and regulation of medical marijuana use vary widely across different regions, reflecting differing societal attitudes and governmental policies toward its use.

MARKET DYNAMICS

The rising recognition of the therapeutic benefits of marijuana is a major driving medical marijuana market. Research and clinical studies have demonstrated its efficacy in treating numerous medical conditions, such as epilepsy, chronic pain, and multiple sclerosis, leading to wider acceptance and adoption in the market. The progressive legalization and regulatory approval of medical marijuana in various regions are significantly boosting the market. As more countries and states legalize its use for medical purposes, the market continues to rise. Additionally, the rising awareness among patients & healthcare providers about the potential health benefits of marijuana is driving market growth. Increased education and information dissemination about its therapeutic uses are encouraging more patients to seek marijuana treatments. Furthermore, advancements in cultivation and extraction technologies are improving the quality and consistency of marijuana products, enhancing their appeal and reliability. These innovations are enabling the production of standardized and high-potency marijuana products, meeting the stringent requirements of the medical community. Moreover, pharmaceutical companies' increasing investment and involvement in the medical marijuana sector contribute to market growth by supporting research, product development, and distribution channels. However, regulatory hurdles and legal complexities may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Marijuana. The growth and trends of Medical Marijuana industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Medical Marijuana market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Flower
Oil & Tinctures

By Application

Cancer
Chronic Pain
Depression and Anxiety
Arthritis
Diabetes
Glaucoma
Migraines
Epilepsy
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Alzheimer's Disease
Post-Traumatic Stress Disorder (PTSD)
Parkinson's Disease
Tourettes
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Marijuana market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Marijuana market include Tilray, Aurora Cannabis, Canopy Growth Corporation, Aphria Inc., Maricann Group Inc., Tikun Olam Ltd., MedReleaf. Corp., GW Pharmaceuticals Plc., Cannabis Sativa Inc., Medical Marijuana Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MEDICAL MARIJUANA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Flower Historic and Forecast Sales By Regions
5.4. Oil & Tinctures Historic and Forecast Sales By Regions

6. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Cancer Historic and Forecast Sales By Regions
6.4. Chronic Pain Historic and Forecast Sales By Regions
6.5. Depression and Anxiety Historic and Forecast Sales By Regions
6.6. Arthritis Historic and Forecast Sales By Regions
6.7. Diabetes Historic and Forecast Sales By Regions
6.8. Glaucoma Historic and Forecast Sales By Regions
6.9. Migraines Historic and Forecast Sales By Regions
6.10. Epilepsy Historic and Forecast Sales By Regions
6.11. Multiple Sclerosis Historic and Forecast Sales By Regions
6.12. AIDS Historic and Forecast Sales By Regions
6.13. Amyotrophic Lateral Sclerosis Historic and Forecast Sales By Regions
6.14. Alzheimer's Disease Historic and Forecast Sales By Regions
6.15. Post-Traumatic Stress Disorder (PTSD) Historic and Forecast Sales By Regions
6.16. Parkinson's Disease Historic and Forecast Sales By Regions
6.17. Tourettes Historic and Forecast Sales By Regions
6.18. Others Historic and Forecast Sales By Regions

7. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MEDICAL MARIJUANA COMPANIES

8.1. Medical Marijuana Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF MEDICAL MARIJUANA INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Tilray
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Aurora Cannabis
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Canopy Growth Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Aphria Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Maricann Group Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Tikun Olam Ltd.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. MedReleaf. Corp.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. GW Pharmaceuticals Plc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Cannabis Sativa Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Medical Marijuana Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments